Gaudium IVF and Women Health IPO sets price band at ₹75 to ₹79 per share; check lot size and key dates

Gaudium IVF and Women Health IPO: Fertility services provider Gaudium IVF and Women Health's initial public offering will open for bidding on Friday, February 20. The issue will end on February 24. The company has set a price band of ₹75 to ₹79 per share.

The initial share sale aims to raise ₹165 crore via fresh issuance of 1,13,92,500 shares valued at ₹90 crore and an offer for sale (OFS) of 94,93,700 shares aggregating to ₹75 crore by promoter Dr Manika Khanna.

The net proceeds from the issue will be utilised for capital expenditure towards the establishment of new IVF centres, repayment of loans availed by the company and corporate general purposes.

"Our company believes that listing will enhance our company's corporate image, brand name and create a public market for its equity shares in India. It will also make future financing easier and affordable in case of expansion or diversification of the business," Gaudium IVF said in its red herring prospectus (RHP).

Gaudium IVF and Women Health IPO: Lot size

A lot consists of 189 shares and in multiples thereafter. Half of the net offer has been reserved for qualified institutional buyers (QIBs), 15% for non-institutional investors (NIIs) and 35% for retail investors.

Gaudium IVF and Women Health IPO: Allotment and listing date

• Gaudium IVF IPO subscription period: February 20 to February 24
• Basis of allotment finalisation: February 25
• Initiation of refunds: February 25
• Credit of shares to Demat account of allottees: February 26
• Listing on NSE and BSE: February 27

Sarthi Capital Advisors is the sole merchant banker for the issue, while Bigshare Services serves as the registrar.

Gaudium IVF and Women Health offers a complete array of specialised fertility and reproductive health services. Having a PAN-India presence, it operates in more than 30 locations, which comprise seven hubs (centres) and 28 spokes (the company has entered into a strategic alliance with Spokes, i.e., Infertility Expert, to achieve the mutual goal of spreading awareness about ART and IVF treatment). It has patients from different countries, such as the United Kingdom, the United States, Kenya, Canada, South Africa and Oman.